COMPASS PATHWAYS PLC (CMPS)

US20451W1018 - ADR

8.32  -1.18 (-12.42%)

After market: 8.48 +0.16 (+1.92%)

Fundamental Rating

2

CMPS gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 592 industry peers in the Biotechnology industry. While CMPS seems to be doing ok healthwise, there are quite some concerns on its profitability. CMPS does not seem to be growing, but still is valued expensively.



1

1. Profitability

1.1 Basic Checks

In the past year CMPS has reported negative net income.
CMPS had a negative operating cash flow in the past year.
CMPS had negative earnings in each of the past 5 years.
In the past 5 years CMPS always reported negative operating cash flow.

1.2 Ratios

CMPS has a Return On Assets of -42.93%. This is comparable to the rest of the industry: CMPS outperforms 57.99% of its industry peers.
Looking at the Return On Equity, with a value of -52.48%, CMPS is in the better half of the industry, outperforming 66.33% of the companies in the same industry.
Industry RankSector Rank
ROA -42.93%
ROE -52.48%
ROIC N/A
ROA(3y)-37.72%
ROA(5y)-40.66%
ROE(3y)-42.73%
ROE(5y)-77.91%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for CMPS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

5

2. Health

2.1 Basic Checks

The number of shares outstanding for CMPS has been increased compared to 1 year ago.
The number of shares outstanding for CMPS has been increased compared to 5 years ago.
The debt/assets ratio for CMPS is higher compared to a year ago.

2.2 Solvency

An Altman-Z score of 4.89 indicates that CMPS is not in any danger for bankruptcy at the moment.
CMPS's Altman-Z score of 4.89 is fine compared to the rest of the industry. CMPS outperforms 77.04% of its industry peers.
CMPS has a Debt/Equity ratio of 0.13. This is a healthy value indicating a solid balance between debt and equity.
CMPS's Debt to Equity ratio of 0.13 is on the low side compared to the rest of the industry. CMPS is outperformed by 66.50% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF N/A
Altman-Z 4.89
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

CMPS has a Current Ratio of 13.33. This indicates that CMPS is financially healthy and has no problem in meeting its short term obligations.
CMPS has a Current ratio of 13.33. This is amongst the best in the industry. CMPS outperforms 86.22% of its industry peers.
CMPS has a Quick Ratio of 13.33. This indicates that CMPS is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 13.33, CMPS belongs to the best of the industry, outperforming 86.56% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 13.33
Quick Ratio 13.33

1

3. Growth

3.1 Past

CMPS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -10.65%.
EPS 1Y (TTM)-10.65%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q27.4%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Revenue growth Q2QN/A

3.2 Future

CMPS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 24.01% yearly.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-1.04%
EPS Next 2Y1.85%
EPS Next 3Y0.97%
EPS Next 5Y24.01%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CMPS. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CMPS. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y1.85%
EPS Next 3Y0.97%

0

5. Dividend

5.1 Amount

No dividends for CMPS!.
Industry RankSector Rank
Dividend Yield N/A

COMPASS PATHWAYS PLC

NASDAQ:CMPS (3/28/2024, 8:02:42 PM)

After market: 8.48 +0.16 (+1.92%)

8.32

-1.18 (-12.42%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap534.37M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -42.93%
ROE -52.48%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 13.33
Quick Ratio 13.33
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-10.65%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y-1.04%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y